Capping Of Coronary Stent Prices In India Is ‘Deeply Disappointing,’ Says US Medtech Body
Executive Summary
The Indian government has fixed the maximum price that can be charged for coronary stents for a year in an attempt to make treatments more affordable. US medtech companies say, however, that a singular focus on pricing is misguided and that steps should be taken to fix “inefficiencies” in the health-care ecosystem.